Ibtrozi may become the new standard for ROS1-mutated lung cancer, with phase 2 data showing safer, longer-lasting benefits ...
A diagnosis of stage 1 urothelial carcinoma can be overwhelming, but it is an early-stage cancer with excellent prognosis and ...
As a metastatic breast cancer patient, I want to control what I can, including my diet and exercise.
Frontline: Surgery (adrenalectomy) to remove the affected adrenal gland is the standard treatment. Second line: Mitotane, a ...
Papillary thyroid cancer is the most common form of thyroid cancer, accounting for about 80% of all thyroid cancer diagnoses. It originates from the follicular cells in the thyroid gland, a ...
Utidelone, previously received orphan drug designation from the FDA for the treatment of breast cancer brain metastases and gastric cancer. The U.S. Food and Drug Administration (FDA) has reportedly ...
Iberdomide combined with standard therapies showed a statistically significant improvement in minimal residual disease (MRD) ...
To confirm a diagnosis and determine the stage of the disease, your doctor will use a series of tests: Biopsy: This is the ...
The regulatory approval of the oral estrogen receptor antagonist is for patients whose cancer has an ESR1 mutation and has ...
“Those women already have a history of cervical cancer; they fought a very strong disease, and unfortunately, our study shows ...
Like gardening, life is a mixture of care, patience, adaptation, and evolution. Each season teaches me something new about ...
Targeted therapies have changed non-small cell lung cancer care, but new side effects, like weight gain, are emerging, says Dr. Lorenzo Belluomini.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results